Level C· Early human research exploring benefitsCase Report / SeriesPubMedOpen access

Lysinibacillus massiliensis Panniculitis Masquerading as Erythema Nodosum: A Case Report.

Jin JJ., Keith PJ., Cummins NW., Kane SV., Pritt BS., Sanchez JL.

Case Report / Series on Autoimmune Research, published in Open Forum Infect Dis (2017) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Open Forum Infect Dis (2017)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
28584854
PMCID
PMC5450899
DOI
10.1093/ofid/ofx072
Citations
4

Abstract (original English)

Lysinibacillus massiliensis , formerly Bacillus massiliensis , is an environmental Gram-positive bacillus that is generally non-pathogenic. Rare case reports in immunosuppressed patients have described sepsis with this organism. In this study, we report a case of L massiliensis as a cause of infectious panniculitis mimicking erythema nodosum after infusion of autologous adipose-derived stem cells in an immunosuppressed patient with refractory Crohn's disease. This case highlights the importance of care providers to consider exposures and host factors when interpreting culture results with otherwise benign organisms.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research